PFM Health Sciences’s Visa V Stock Holding History

PFM Health Sciences’s Portfolio V Stock Details V Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-43,468	Closed	-$8.69M	–	105
2020 Q3	$8.69M	Hold	43,468	–	–	0.4%	63
2020 Q2	$8.4M	Buy	+43,468	New	+$7.94M	0.44%	66
2019 Q4	–	Sell	-134,188	Closed	-$23.1M	–	79
2019 Q3	$23.1M	Buy	+134,188	New	+$23.9M	0.68%	44
2017 Q4	–	Sell	-190,147	Closed	-$20M	–	100
2017 Q3	$20M	Sell	190,147 -371,543	-66%	-$37.7M	0.39%	71
2017 Q2	$52.7M	Buy	561,690 +275,675	+96%	+$25.6M	1.42%	28
2017 Q1	$25.4M	Buy	+286,015	New	+$24.6M	0.64%	59
2016 Q4	–	Sell	-792,535	Closed	-$65.5M	–	117
2016 Q3	$65.5M	Buy	792,535 +556,663	+236%	+$44.6M	1.92%	18
2016 Q2	$17.5M	Buy	+235,872	New	+$18.5M	0.53%	56
2015 Q1	–	Sell	-792,916	Closed	-$52M	–	100
2014 Q4	$52M	Buy	+792,916	New	+$47.7M	1.21%	29
2013 Q3	–	Sell	-1,111,368	Closed	-$50.8M	–	89
2013 Q2	$50.8M	Buy	+1,111,368	New	+$48.6M	1.05%	31

Other funds holding V

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

PFM Health Sciences's V Position: Q4 2020 in Review

PFM Health Sciences sold out of Visa (V) in Q4 2020, closing a stake of 43,468 shares — an estimated $8.69M sold.

PFM Health Sciences first reported a position in V in Q2 2013 and held it in 10 quarters. The position peaked at $65.5M in Q3 2016. 3,024 funds tracked by Wall St. Rank hold V as of Q4 2020.

PFM Health Sciences reported no remaining Visa position as of Q4 2020 after selling out during the quarter.
PFM Health Sciences sold 43,468 Visa shares in Q4 2020, an estimated $8.69M.
PFM Health Sciences first reported a position in Visa in Q2 2013 and held it in 10 quarters.
PFM Health Sciences's Visa position peaked at $65.5M in Q3 2016.
3,024 funds tracked by Wall St. Rank held Visa as of Q4 2020.

Based on PFM Health Sciences's 13F filing for Q4 2020, filed 16 Feb 2021.